UA101304C2 - Способы введения гипогликемических средств продленного действия - Google Patents
Способы введения гипогликемических средств продленного действияInfo
- Publication number
- UA101304C2 UA101304C2 UAA200902200A UAA200902200A UA101304C2 UA 101304 C2 UA101304 C2 UA 101304C2 UA A200902200 A UAA200902200 A UA A200902200A UA A200902200 A UAA200902200 A UA A200902200A UA 101304 C2 UA101304 C2 UA 101304C2
- Authority
- UA
- Ukraine
- Prior art keywords
- heading
- methods
- normal
- hypoglycemic agents
- administering
- Prior art date
Links
- 239000003472 antidiabetic agent Substances 0.000 title abstract 3
- 229940126904 hypoglycaemic agent Drugs 0.000 title abstract 3
- 102100025101 GATA-type zinc finger protein 1 Human genes 0.000 abstract 1
- 101710198884 GATA-type zinc finger protein 1 Proteins 0.000 abstract 1
- DTHNMHAUYICORS-KTKZVXAJSA-N Glucagon-like peptide 1 Chemical compound C([C@@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCCN)C(=O)NCC(=O)N[C@@H](CCCNC(N)=N)C(N)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@H](CCC(N)=O)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CC=1N=CNC=1)[C@@H](C)O)[C@@H](C)O)C(C)C)C1=CC=CC=C1 DTHNMHAUYICORS-KTKZVXAJSA-N 0.000 abstract 1
- 239000000556 agonist Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000036470 plasma concentration Effects 0.000 abstract 1
- 230000002459 sustained effect Effects 0.000 abstract 1
Landscapes
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Данное изобретение относится к способам и фармацевтическим композициям, связанных с введением гипогликемических средств и агонистов GLP-1, причем средние значения максимальной концентрации в плазме (Cmax) и площади под кривой (AUC) для гипогликемического средства повышены и/или длительно сохраняются.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US82547206P | 2006-09-13 | 2006-09-13 | |
| PCT/US2007/078226 WO2008033888A2 (en) | 2006-09-13 | 2007-09-12 | Methods for administering long-lasting hypoglycemic agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| UA101304C2 true UA101304C2 (ru) | 2013-03-25 |
Family
ID=41040422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| UAA200902200A UA101304C2 (ru) | 2006-09-13 | 2007-09-12 | Способы введения гипогликемических средств продленного действия |
Country Status (2)
| Country | Link |
|---|---|
| CN (1) | CN101516391A (ru) |
| UA (1) | UA101304C2 (ru) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202423476A (zh) * | 2021-03-23 | 2024-06-16 | 美商美國禮來大藥廠 | 含腸促胰島素(incretin)類似物之組合物及其用途 |
-
2007
- 2007-09-12 UA UAA200902200A patent/UA101304C2/ru unknown
- 2007-09-12 CN CNA2007800341061A patent/CN101516391A/zh active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| CN101516391A (zh) | 2009-08-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY149911A (en) | Methods for administering long-lasting hypoglycemic agents | |
| MX2009005048A (es) | Nuevo proceso para la preparacion de derivados de 2-imino-tiazolidin-4-ona. | |
| WO2009109927A3 (en) | Glp-1 receptor agonists and related active pharmaceutical ingredients for treatment of cancer | |
| TNSN07341A1 (en) | Pharmaceutical composition comprising an omega-carboxyaryl substituted diphenyl urea for the treatment of cancer | |
| PT2038290E (pt) | Moduladores de receptor do tipo toll 7 | |
| MX2009004475A (es) | Composiciones que comprenden agentes acido labiles que inhiben la bomba de protones, por lo menos otro agente farmaceuticamente activo y metodos de uso de las misma. | |
| TNSN08365A1 (en) | Sustained release pharmaceutical composition on the basis of release system comprising an acid-soluble polymer and a ph-dependent polymer | |
| UA101313C2 (ru) | Еженедельное введение ингибиторов дипептидилпептидазы | |
| MY138708A (en) | Biaryloxymethylarenecarboxylic acids | |
| WO2005112633A3 (en) | Compounds and compositions for delivering active agents | |
| MY150682A (en) | Method for using vasopressin antagonist with anthracycline chemotherapy agents to reduce cardiotoxicity and/or improve survival | |
| WO2008042480A3 (en) | Epoxide inhibitors of cysteine proteases | |
| WO2007046868A3 (en) | Thiazolidine derivatives and their uses as therapeutic agents | |
| WO2008079270A3 (en) | Coadministration of alpha-fetoprotein and an immunomodulatory agent to treat multiple sclerosis | |
| TW200633992A (en) | Biaryloxymethylarenecarboxylic acids | |
| CY1109537T1 (el) | Πεπτιδια και παραγωγα πεπτιδιου, παρασκευη αυτων καθως επισης χρηση αυτων για την παρασκευη θεραπευτικως η/και προληπτικως δραστικης φαρμακευτικης συνθεσης | |
| WO2006089114A3 (en) | Methods and compositions for treating an anthrax toxin mediated condition | |
| WO2007095250A3 (en) | Compositions and methods for inhibiting optic nerve damage | |
| MX2009005798A (es) | Recuperacion de apoplejia. | |
| MX2010004556A (es) | Formulacion farmaceutica de acido clavulanico. | |
| GB2446341A (en) | Method and system for transdermal drug delivery | |
| UA96277C2 (en) | Benzimidazole derivatives | |
| UA101304C2 (ru) | Способы введения гипогликемических средств продленного действия | |
| WO2008057464A3 (en) | Compositions and methods for improving the bioavailability of liothyronine | |
| WO2007121471A3 (en) | Dialkyl ether delivery agents |